NCT04681222 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Girón-Arango L, Peng PWH, Chin KJ, Brull R, Perlas A
Pericapsular Nerve Group (PENG) Block for Hip Fracture. Reg Anesth Pain Med. 2018 Nov;43(8):859-863. doi: 10.1097/AAP.0000000000000847.
Girón-Arango L, Roqués V, Peng P
Reply To Dr Roy et al: Total postoperative analgesia for hip surgeries: PENG block with LFCN block. Reg Anesth Pain Med. 2019 Mar 28. pii: rapm-2019-100505. doi: 10.1136/rapm-2019-100505. [Epub ahead of print]
Mistry T, Sonawane KB, Kuppusamy E
PENG block: points to ponder. Reg Anesth Pain Med. 2019 Jan 11. pii: rapm-2018-100327. doi: 10.1136/rapm-2018-100327. [Epub ahead of print]
Nersesjan M, Hägi-Pedersen D, Andersen JH, Mathiesen O, Dahl JB, Broeng L, Thybo KH
Sensory distribution of the lateral femoral cutaneous nerve block - a randomised, blinded trial. Acta Anaesthesiol Scand. 2018 Jul;62(6):863-873. doi: 10.1111/aas.13091. Epub 2018 Feb 21.
Roy R, Agarwal G, Pradhan C, Kuanar D
Total postoperative analgesia for hip surgeries, PENG block with LFCN block. Reg Anesth Pain Med. 2019 Mar 28. pii: rapm-2019-100454. doi: 10.1136/rapm-2019-100454. [Epub ahead of print]

Postoperative Pain Management in Patients Undergoing Total Hip Arthroplasty: PENG Block in Combination With LFCN Block or Wound Infiltration?

Clinical trial NCT04681222 - References